Search

Your search keyword '"Huber, Wolf-Dietrich"' showing total 206 results

Search Constraints

Start Over You searched for: Author "Huber, Wolf-Dietrich" Remove constraint Author: "Huber, Wolf-Dietrich"
206 results on '"Huber, Wolf-Dietrich"'

Search Results

1. Maralixibat in progressive familial intrahepatic cholestasis (MARCH-PFIC): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

2. Langerhans Cell Histiocytosis or Acute Cellular Rejection?

4. Kinesin family member 12‐related hepatopathy: A generally indolent disorder with elevated gamma‐glutamyl‐transferase activity.

7. Analysis of safety in maralixibat-treated participants with progressive familial intrahepatic cholestasis: data from MARCH-PFIC

8. Long-term maintenance of response and improved liver health with maralixibat in patients with progressive familial intrahepatic cholestasis (PFIC): data from the MARCH-ON study

10. The influence of liver transplantation on the interplay between gut microbiome and bile acid homeostasis in children with biliary atresia

12. Publisher Correction: Human DEF6 deficiency underlies an immunodeficiency syndrome with systemic autoimmunity and aberrant CTLA-4 homeostasis

13. Human DEF6 deficiency underlies an immunodeficiency syndrome with systemic autoimmunity and aberrant CTLA-4 homeostasis

26. WED-282 - Analysis of safety in maralixibat-treated participants with progressive familial intrahepatic cholestasis: data from MARCH-PFIC

27. LBP-35 - Long-term maintenance of response and improved liver health with maralixibat in patients with progressive familial intrahepatic cholestasis (PFIC): data from the MARCH-ON study

37. Characteristics, management, and outcome of pediatric patients with post‐transplant lymphoproliferative disease—A 20 years' experience from Austria.

39. BMC Gastroenterology / Vedolizumab use after failure of TNF- antagonists in children and adolescents with inflammatory bowel disease

40. PD‐L1 and PD1 expression in post‐transplantation lymphoproliferative disease (PTLD) of childhood and adolescence: An inter‐ and intra‐individual descriptive study covering the whole spectrum of PTLD categories

42. Golimumab in adolescents with Crohn's disease refractory to previous tumour necrosis factor antibody.

44. Pediatric gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) and European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) Guideline Executive summary

47. Immunosuppressive therapy does not prevent the occurrence of immunoglobulin E-mediated allergies in children and adolescents with organ transplants

Catalog

Books, media, physical & digital resources